Tecrea Ltd. is thrilled to announce the successful completion of the NBIC FTMA award, which was used for an industry-academia exchange and collaboration with the Bladder Infection and Immunity Group, UCL. This grant has facilitated a fruitful exchange of knowledge and expertise.

The grant was used advanced imaging training of uropathogenic and commensal biofilms. This training has equipped our team with cutting-edge techniques to visualize and understand the complex interactions within biofilms, which play a crucial role in bladder infections.

Moreover, the grant enabled the evaluation of Tecrea’s innovative Nanocin technology for its anti-uropathogenic action. This evaluation marks a significant step forward in our commitment to developing novel solutions for combating uropathogenic bacteria, with the potential to revolutionize treatment strategies for bladder infections.

We extend our gratitude to the National Biofilms Innovation Centre (NBIC) for their support through the FTMA award. We look forward to further collaboration with BIIG to make strides in biofilm research and nanotechnology applications in urogynaecology.

Stay tuned for further updates on our ongoing research and future endeavors.


This news post is for informational purposes only and does not constitute a formal publication or scientific endorsement of the technologies mentioned.